Bio-RadBIO
NYSELaboratory Instruments
No cached AI snapshot yet for BIO.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
7,450 employees26.99M shares outstandinglisted 1980-02-29
Next earnings ~May 5, 2026
About Bio-Rad
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Latest News
Showing market-wide stock news
FOMC preview: Rate hike priced in as markets await policy guidance
AM Markets Need to Know: Fed hike, AWS Gulf loss, and more
Euro: Firm Dollar keeps pressure on Euro before FOMC - Danske Bank
FOMC day
Bitcoin retreats after crypto bill setback, Fed next
This BlackRock strategist opposes a Fed hike. Here are the funds she recommends.
Related Stocksin Laboratory Instruments
Ready to see the live AI view on BIO?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing BIO side-by-side with live signals.